首页> 外文期刊>Genetic testing and molecular biomarkers >Variations in the PDCD6 Gene Are Associated with Increased Uterine Leiomyoma Risk in the Chinese
【24h】

Variations in the PDCD6 Gene Are Associated with Increased Uterine Leiomyoma Risk in the Chinese

机译:PDCD6基因的变异与中国子宫平滑肌瘤的风险增加有关

获取原文
获取原文并翻译 | 示例
       

摘要

Programmed cell death 6 (PDCD6) participates in T cell receptor, Fas, and glucocorticoid-induced programmed cell death. To test the relationship between PDCD6 polymorphisms and uterine leiomyomas (UL) risk, we investigated the association of two SNPs (rs4957014 and rs3756712) in PDCD6 with UL risk in a case-control study of 295 unrelated premenopausal UL patients and 436 healthy postmenopausal control subjects in a population of China. Genotypes of the two SNPs were determined with the use of PCR-restriction fragment length polymorphism assay. Significantly increased UL risks were found to be associated with the T allele of rs4957014 and the T allele of rs3756712 (p=0.016, odds ratio [OR] = 1.325, 95% confidence intervals [CI] = 1.053-1.668 for rs4957014; p< 0.0001, OR=1.898, 95% CI=1.457-2.474 for rs3756712, respectively). Increased UL risks were associated with them in different genetic models. The present study provided evidence that rs4957014 and rs3756712 are associated with UL risk, the results indicated that genetic polymorphisms in PDCD6 may contribute to the development of UL.
机译:程序性细胞死亡6(PDCD6)参与T细胞受体,Fas和糖皮质激素诱导的程序性细胞死亡。为了测试PDCD6多态性与子宫平滑肌瘤(UL)风险之间的关系,我们在一项295例无关的绝经前UL患者和436例绝经后健康对照者的病例对照研究中,研究了PDCD6中的两个SNP(rs4957014和rs3756712)与UL风险的关系。在中国人口中使用PCR-限制性片段长度多态性测定法确定了两个SNP的基因型。发现UL风险显着升高与rs4957014的T等位基因和rs3756712的T等位基因相关(p = 0.016,比值比[OR] = 1.325,rs4957014的95%置信区间[CI] = 1.053-1.668; p < rs3756712分别为0.0001,OR = 1.898、95%CI = 1.457-2.474)。在不同的遗传模型中,UL风险增加与它们相关。本研究提供了rs4957014和rs3756712与UL风险相关的证据,结果表明PDCD6中的遗传多态性可能有助于UL的发展。

著录项

  • 来源
    《Genetic testing and molecular biomarkers》 |2013年第7期|524-528|共5页
  • 作者单位

    Department of Forensic Biology, West China School of Preclinical and Forensic Medicine, Sichuan University, Chengdu, People's Republic of China;

    Laboratory of Molecular Translational Medicine, Key Laboratory of Obstetric & Gynecologic and Pediatric Diseases and Birth Defects of Ministry of Education, West China Institute of Women and Children's Health, West China Second University Hospital, Sichuan University, Chengdu, People's Republic of China;

    Department of Immunology, West China School of Preclinical and Forensic Medicine, Sichuan University, Chengdu, People's Republic of China;

    Laboratory of Molecular Translational Medicine, Key Laboratory of Obstetric & Gynecologic and Pediatric Diseases and Birth Defects of Ministry of Education, West China Institute of Women and Children's Health, West China Second University Hospital, Sichuan University, Chengdu, People's Republic of China;

    Department of Forensic Biology West China School of Preclinical and Forensic Medicine Sichuan University Chengdu 610041 People's Republic of China Laboratory of Molecular Translational Medicine, Key Laboratory of Obstetric & Gynecologic and Pediatric Diseases and Birth Defects of Ministry of Education, West China Institute of Women and Children's Health, West China Second University Hospital, Sichuan University, Chengdu, People's Republic of China;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-17 13:17:35

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号